Edithistory:SEE-FIM Protocol
From EverybodyWiki Bios & Wiki
| oldid | date/time | username | edit summary |
|---|---|---|---|
| 1159684123 | 2023-06-11T22:07:13Z | Citation bot | Removed parameters. | [[WP:UCB|Use this bot]]. [[WP:DBUG|Report bugs]]. | Suggested by Headbomb | #UCB_toolbar |
| 1153188345 | 2023-05-04T18:50:55Z | Cmastr48 | /* 5.3 Surgical excision specimens from women with HGSC */ |
| 1153188219 | 2023-05-04T18:50:01Z | Cmastr48 | /* 5.3 Surgical excision specimens from women with HGSC */ |
| 1153013342 | 2023-05-03T17:46:00Z | Cmastr48 | /* 5.3 Surgical excision specimens from women with HGSC */ |
| 1153013303 | 2023-05-03T17:45:37Z | Cmastr48 | /* 5.3 Surgical excision specimens from women with HGSC */ |
| 1151826246 | 2023-04-26T13:43:27Z | Cmastr48 | Submitting using [[WP:AFCSW|AfC-submit-wizard]] |
| 1151825426 | 2023-04-26T13:36:21Z | Cmastr48 | |
| 1151824236 | 2023-04-26T13:25:29Z | Cmastr48 | /* 5.3 Surgical excision specimens from women with HGSC */ |
| 1151824180 | 2023-04-26T13:24:50Z | Cmastr48 | /* 5.3 Surgical excision specimens from women with HGSC */ |
| 1151823729 | 2023-04-26T13:21:13Z | Cmastr48 | /* 5.2 Opportunistic salpingectomy */ |
| 1151823513 | 2023-04-26T13:19:27Z | Cmastr48 | /* 5.2 Opportunistic salpingectomy */ |
| 1151823336 | 2023-04-26T13:18:48Z | Cmastr48 | /* 5.1 Prophylactic salpingectomy */ |
| 1151823035 | 2023-04-26T13:18:10Z | Cmastr48 | /* 5.1 Prophylactic salpingectomy */ |
| 1151821822 | 2023-04-26T13:16:05Z | Cmastr48 | /* 5.1 Prophylactic salpingectomy */ |
| 1151821202 | 2023-04-26T13:12:14Z | Cmastr48 | /* 2.1 Conception */ |
| 1151671581 | 2023-04-25T14:00:59Z | Cmastr48 | /* 8 Abbreviations */ |
| 1151671250 | 2023-04-25T13:58:32Z | Cmastr48 | /* 5.2 Opportunistic salpingectomy */ |
| 1151671027 | 2023-04-25T13:56:47Z | Cmastr48 | /* 5. Indications for the Protocol */ |
| 1151670959 | 2023-04-25T13:56:12Z | Cmastr48 | /* 4 Acceptance in pathology practice */ |
| 1151670790 | 2023-04-25T13:54:59Z | Cmastr48 | /* 2.1 Conception */ |
| 1151551303 | 2023-04-24T19:13:29Z | Cmastr48 | /* 5.3 Surgical excision specimens from women with HGSC */ |
| 1151551195 | 2023-04-24T19:12:42Z | Cmastr48 | /* 5.3 Surgical excision specimens from women with HGSC */ |
| 1151550770 | 2023-04-24T19:09:03Z | Cmastr48 | /* 2.1 Conception */ |
| 1151550689 | 2023-04-24T19:08:29Z | Cmastr48 | /* 2 Background */ |
| 1151550595 | 2023-04-24T19:07:38Z | Cmastr48 | /* 2 Background */ |
| 1151550115 | 2023-04-24T19:03:53Z | Cmastr48 | /* 1 Definition */ |
| 1151550030 | 2023-04-24T19:03:08Z | Cmastr48 | /* 5.14 Complementary clinical studies confirming the link between the distal fallopian tube and HGSC */ |
| 1151549875 | 2023-04-24T19:01:55Z | Cmastr48 | /* 5.142 Applications of SEE-FIM to ascertain recurrence risk in patient care. */ |
| 1151549755 | 2023-04-24T19:00:59Z | Cmastr48 | /* 5.12 Prevention of HGSC in high risk women by risk reduction salpingectomy (RRS) */ |
| 1151549613 | 2023-04-24T18:59:59Z | Cmastr48 | /* 5.141 Determining the prevalence of early cancers (STICs) in the general population */ |
| 1151549534 | 2023-04-24T18:59:22Z | Cmastr48 | /* 5 Protocol contribution to the field of ovarian cancer pathogenesis and prevention */ |
| 1151549309 | 2023-04-24T18:57:30Z | Cmastr48 | /* 5.13 Discovery of and characterization of a serous carcinogenic “sequence” in the fimbria */ |
| 1151549239 | 2023-04-24T18:56:51Z | Cmastr48 | /* 2.1 Prevention of ovarian cancer in women with mutations in BRCA1 and BRCA2 by risk reduction salpingo-oophorectomy (RRSO) */ |
| 1151548981 | 2023-04-24T18:54:46Z | Cmastr48 | /* 4.1 Validation */ |
| 1151548917 | 2023-04-24T18:54:15Z | Cmastr48 | /* 5.12 Linking the fallopian tube to advanced cases of HGSC */ |
| 1151548729 | 2023-04-24T18:52:30Z | Cmastr48 | /* 2.1 Conception */ |
| 1151519617 | 2023-04-24T15:31:39Z | Cmastr48 | /* 5.12 Linking the fallopian tube to advanced cases of HGSC */ |
| 1151519498 | 2023-04-24T15:30:36Z | Cmastr48 | /* 5. Indications for the Protocol */ |
| 1151518522 | 2023-04-24T15:24:55Z | Cmastr48 | /* 5. Indications for the Protocol */ |
| 1151516488 | 2023-04-24T15:10:36Z | Cmastr48 | /* 4 Application to pathology practice */ |
| 1151516257 | 2023-04-24T15:08:58Z | Cmastr48 | /* 5. Discoveries */ |
| 1151516117 | 2023-04-24T15:07:59Z | Cmastr48 | /* 4.1 Use and validation */ |
| 1151515850 | 2023-04-24T15:05:50Z | Cmastr48 | /* 4.3 Variation in SEE-FIM or similar protocols */ |
| 1151515689 | 2023-04-24T15:04:38Z | Cmastr48 | /* 4.2 Acceptance by societies and use in large studies. */ |
| 1151515591 | 2023-04-24T15:03:59Z | Cmastr48 | /* 4.1 Use and validation */ |
| 1151515532 | 2023-04-24T15:03:32Z | Cmastr48 | /* 4 Application to pathology practice */ |
| 1151514971 | 2023-04-24T15:00:24Z | Cmastr48 | /* 3.2 Method */ |
| 1151514841 | 2023-04-24T14:59:42Z | Cmastr48 | /* 2.1 Conception */ |
| 1151514470 | 2023-04-24T14:57:02Z | Cmastr48 | /* 2.1 Conception */ |
| 1151513973 | 2023-04-24T14:53:36Z | Cmastr48 | /* 3.1 Conception */ |
| 1151513244 | 2023-04-24T14:48:42Z | Cmastr48 | /* 2 Background */ |
| 1151513083 | 2023-04-24T14:47:30Z | Cmastr48 | /* 2.31 Discovery of the Breast Cancer susceptibility gene (BRCA) */ |
| 1151512925 | 2023-04-24T14:46:17Z | Cmastr48 | /* 1 Definition */ |
| 1151512856 | 2023-04-24T14:45:46Z | Cmastr48 | /* 2.3 Emerging role of the fallopian tube ovarian carcinogenesis */ |
| 1151512778 | 2023-04-24T14:45:17Z | Cmastr48 | /* 1 Definition */ |
| 1151512691 | 2023-04-24T14:44:34Z | Cmastr48 | /* 2 Background */ |
| 1151374516 | 2023-04-23T17:02:11Z | Cmastr48 | /* 5.142 Applications of SEE-FIM to ascertain recurrence risk in patient care. */ |
| 1151374411 | 2023-04-23T17:01:33Z | Cmastr48 | /* 5.142 Applications of SEE-FIM to ascertain recurrence risk in patient care. */ |
| 1151373802 | 2023-04-23T16:57:00Z | Cmastr48 | /* 5.142 Applications of SEE-FIM to ascertain recurrence risk in patient care. */ |
| 1151373688 | 2023-04-23T16:55:53Z | Cmastr48 | /* 5.13 Discovery of and characterization of a serous carcinogenic “sequence” in the fimbria */ |
| 1151373598 | 2023-04-23T16:55:08Z | Cmastr48 | /* 5.13 Discovery of and characterization of a serous carcinogenic “sequence” in the fimbria */ |
| 1151373406 | 2023-04-23T16:53:29Z | Cmastr48 | /* 5.13 Discovery of and characterization of a serous carcinogenic “sequence” in the fimbria */ |
| 1151372874 | 2023-04-23T16:49:25Z | Cmastr48 | /* 5.12 Linking the fallopian tube to advanced cases of HGSC */ |
| 1151372684 | 2023-04-23T16:48:05Z | Cmastr48 | /* 5.12 Linking the fallopian tube to advanced cases of HGSC */ |
| 1151372633 | 2023-04-23T16:47:36Z | Cmastr48 | /* 5.12 Linking the fallopian tube to advanced cases of HGSC */ |
| 1151372239 | 2023-04-23T16:44:30Z | Cmastr48 | /* 5.12 Linking the fallopian tube to advanced cases of HGSC */ |
| 1151371887 | 2023-04-23T16:41:25Z | Cmastr48 | /* 5.11 Early detection of STICs or early HGSC in RRSOs in the fimbria of women with BRCA mutations */ |
| 1151371489 | 2023-04-23T16:38:40Z | Cmastr48 | /* 4.3 Variation in SEE-FIM or similar protocols */ |
| 1151371288 | 2023-04-23T16:36:58Z | Cmastr48 | /* 4.2 Acceptance by societies and use in large studies. */ |
| 1151371129 | 2023-04-23T16:35:52Z | Cmastr48 | /* 4.2 Acceptance by societies and use in large studies. */ |
| 1151370528 | 2023-04-23T16:31:04Z | Cmastr48 | /* 3.2 Method */ |
| 1151370329 | 2023-04-23T16:29:15Z | Cmastr48 | /* 3.1 Conception */ |
| 1151370230 | 2023-04-23T16:28:27Z | Cmastr48 | /* 3.1 Conception */ |
| 1151369767 | 2023-04-23T16:24:31Z | Cmastr48 | /* 3.1 Conception */ |
| 1151369398 | 2023-04-23T16:21:11Z | Cmastr48 | /* 3.1 Conception */ |
| 1151369095 | 2023-04-23T16:18:28Z | Cmastr48 | /* 2.3 Extrauterine high grade serous cancer (HGSC) of the Ovary and Fallopian tube */ |
| 1151177033 | 2023-04-22T11:31:34Z | Tom (LT) | Declining submission: not - Submission fails [[Wikipedia:What Wikipedia is not]] and This article is very confusing. What's the primary topic? Remove the extraneous detail and it seems basically to be abou... ([[WP:AFCH|AFCH]] 0.9.1) |
| 1150889411 | 2023-04-20T16:47:18Z | Cmastr48 | /* 5.142 Applications of SEE-FIM to ascertain recurrence risk in patient care. */ |
| 1150889263 | 2023-04-20T16:46:12Z | Cmastr48 | /* 5.142 Applications of SEE-FIM to ascertain recurrence risk in patient care. */ |
| 1150889153 | 2023-04-20T16:45:29Z | Cmastr48 | /* 5.142 Applications of SEE-FIM to ascertain recurrence risk in patient care. */ |
| 1150888814 | 2023-04-20T16:43:12Z | Cmastr48 | /* 5.13 Discovery of and characterization of a serous carcinogenic “sequence” in the fimbria */ |
| 1150888486 | 2023-04-20T16:41:10Z | Cmastr48 | /* 5.12 Linking the fallopian tube to advanced cases of HGSC */ |
| 1150888436 | 2023-04-20T16:40:45Z | Cmastr48 | /* 5.11 Early detection of STICs or early HGSC in RRSOs in the fimbria of women with BRCA mutations */ |
| 1150888377 | 2023-04-20T16:40:18Z | Cmastr48 | /* 4.1 Use and validation */ |
| 1150876976 | 2023-04-20T15:34:54Z | Cmastr48 | /* 5.12 Prevention of HGSC in high risk women by risk reduction salpingectomy (RRS) */ |
| 1150876659 | 2023-04-20T15:33:10Z | Cmastr48 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150876147 | 2023-04-20T15:30:05Z | Cmastr48 | /* 7 See also */ |
| 1150875041 | 2023-04-20T15:23:45Z | Cmastr48 | /* 3.1 Conception */ |
| 1150874908 | 2023-04-20T15:22:59Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1150874688 | 2023-04-20T15:21:47Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1150874008 | 2023-04-20T15:17:34Z | Cmastr48 | /* 3.1 Conception */ |
| 1150873828 | 2023-04-20T15:16:34Z | Cmastr48 | /* 3.1 Conception */ |
| 1150873137 | 2023-04-20T15:12:10Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1150863133 | 2023-04-20T14:16:35Z | Cmastr48 | /* 2.1 Functional anatomy of the fallopian tube */ |
| 1150862812 | 2023-04-20T14:14:55Z | Cmastr48 | /* 3.1 Conception */ |
| 1150758686 | 2023-04-20T00:34:18Z | Cmastr48 | /* 3.1 Conception */ |
| 1150758524 | 2023-04-20T00:32:52Z | Cmastr48 | /* 3.1 Conception */ |
| 1150758465 | 2023-04-20T00:32:21Z | Cmastr48 | /* 3.1 Conception */ |
| 1150758297 | 2023-04-20T00:31:17Z | Cmastr48 | /* 3.1 Conception */ |
| 1150758087 | 2023-04-20T00:30:10Z | Cmastr48 | /* 3.2 Method */ |
| 1150758019 | 2023-04-20T00:29:23Z | Cmastr48 | /* 3.1 Conception */ |
| 1150757946 | 2023-04-20T00:28:52Z | Cmastr48 | /* 3.2 Method */ |
| 1150757498 | 2023-04-20T00:26:50Z | Cmastr48 | /* 3.1 Conception */ |
| 1150757080 | 2023-04-20T00:23:47Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1150721773 | 2023-04-19T19:51:20Z | Cmastr48 | /* 8 Abbreviations */ |
| 1150665468 | 2023-04-19T12:22:29Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1150665336 | 2023-04-19T12:21:25Z | Cmastr48 | /* 3.2 Method */ |
| 1150665108 | 2023-04-19T12:19:40Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1150474519 | 2023-04-18T11:48:57Z | 209.6.133.54 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150474194 | 2023-04-18T11:46:06Z | 209.6.133.54 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150473823 | 2023-04-18T11:43:12Z | 209.6.133.54 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150473342 | 2023-04-18T11:39:16Z | 209.6.133.54 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150473287 | 2023-04-18T11:38:42Z | 209.6.133.54 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150472902 | 2023-04-18T11:35:38Z | 209.6.133.54 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150472848 | 2023-04-18T11:35:14Z | 209.6.133.54 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150472773 | 2023-04-18T11:34:29Z | 209.6.133.54 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1150471495 | 2023-04-18T11:24:42Z | 209.6.133.54 | /* 3.1 Conception */ |
| 1150471395 | 2023-04-18T11:23:59Z | 209.6.133.54 | /* 3.1 Conception */ |
| 1150414448 | 2023-04-18T01:17:03Z | 209.6.133.54 | /* 5.12 Prevention of HGSC in high risk women by risk reduction salpingectomy (RRS) */ |
| 1150318616 | 2023-04-17T13:03:02Z | AManWithNoPlan | got doi fixed |
| 1150217481 | 2023-04-16T23:12:07Z | Headbomb | ce |
| 1150216968 | 2023-04-16T23:07:58Z | Headbomb | ce |
| 1150216791 | 2023-04-16T23:06:36Z | Citation bot | Add: doi-broken-date. | [[WP:UCB|Use this bot]]. [[WP:DBUG|Report bugs]]. | Suggested by Headbomb | #UCB_toolbar |
| 1149690822 | 2023-04-13T20:42:52Z | Cmastr48 | /* 5.12 Prevention of HGSC in high risk women by risk reduction salpingectomy (RRS) */ |
| 1149690696 | 2023-04-13T20:41:47Z | Cmastr48 | /* 5.11 Prevention of HGSC in women at low risk */ |
| 1149690286 | 2023-04-13T20:38:32Z | Cmastr48 | /* 5.12 Prevention of HGSC in high risk women by risk reduction salpingectomy (RRS) */ |
| 1149690166 | 2023-04-13T20:37:33Z | Cmastr48 | /* 5.1 Prevention of HGSC by salpingectomy */ |
| 1149689277 | 2023-04-13T20:30:15Z | Cmastr48 | /* 5.13 Discovery of and characterization of a serous carcinogenic “sequence” in the fimbria */ |
| 1149688891 | 2023-04-13T20:26:56Z | Cmastr48 | /* 5.13 Discovery of and characterization of a serous carcinogenic “sequence” in the fimbria */ |
| 1149688234 | 2023-04-13T20:21:21Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1149688120 | 2023-04-13T20:20:28Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1149688027 | 2023-04-13T20:19:37Z | Cmastr48 | /* 3 Introduction of the SEE-FIM protocol */ |
| 1149687839 | 2023-04-13T20:18:05Z | Cmastr48 | /* 2.32 Prevention of ovarian cancer in women with mutations in BRCA1 and BRCA2 by risk reduction salpingo-oophorectomy (RRSO) */ |
| 1149687360 | 2023-04-13T20:14:24Z | Cmastr48 | /* 2.31 Discovery of the Breast Cancer susceptibility gene (BRCA) */ |
| 1149532259 | 2023-04-12T20:25:07Z | Citation bot | Alter: date, pages, title, journal. Add: pmc-embargo-date, hdl, s2cid, authors 1-1. Removed proxy/dead URL that duplicated identifier. Removed parameters. Formatted [[WP:ENDASH|dashes]]. Some additions/deletions were parameter name changes. | [[WP:UCB|Use this bot]]. [[WP:DBUG|Report bugs]]. | Suggested by GoingBatty | #UCB_toolbar |
| 1149418778 | 2023-04-12T03:29:16Z | BattyBot | Fixed reference date error(s) (see [[:Category:CS1 errors: dates|CS1 errors: dates]] for details) and [[WP:AWB/GF|AWB general fixes]] |
| 1149387973 | 2023-04-11T22:35:05Z | RichBot | ([[WP:BOT|Beep, Boop]]). I have removed a template which is not valid in Draftspace |
| 1149387649 | 2023-04-11T22:31:53Z | P53Signature | P53Signature moved page [[User:P53Signature/SEE-FIM Protocol]] to [[Draft:SEE-FIM Protocol]]: Preferred location for [[WP:AFC|AfC]] submissions |
| 1149382602 | 2023-04-11T21:48:02Z | P53Signature | Submitting using [[WP:AFCSW|AfC-submit-wizard]] |
| 1149382369 | 2023-04-11T21:46:06Z | P53Signature | /* 3 Introduction of the SEE-FIM protocol */ |
| 1149382303 | 2023-04-11T21:45:36Z | P53Signature | |
| 1149318109 | 2023-04-11T13:33:25Z | P53Signature | |
| 1149314546 | 2023-04-11T13:06:31Z | P53Signature | |
| 1149201709 | 2023-04-10T19:20:57Z | P53Signature | /* 4.3 Variation in SEE-FIM or similar protocols */ |
| 1149199981 | 2023-04-10T19:09:09Z | P53Signature | /* 3 introduction of the SEE-FIM protocol */ |
| 1149181434 | 2023-04-10T16:54:27Z | P53Signature | |
| 1149174730 | 2023-04-10T16:08:52Z | P53Signature | |
| 1149166179 | 2023-04-10T15:12:55Z | P53Signature | |
| 1149166029 | 2023-04-10T15:12:04Z | P53Signature | /* 5.2 Prevention of HGSC by salpingectomy */ |
| 1149165984 | 2023-04-10T15:11:47Z | P53Signature | |
| 1149165498 | 2023-04-10T15:08:53Z | P53Signature | [[WP:AES|←]]Created page with '{{Userspace draft|source=ArticleWizard|date={{Subst:CURRENTMONTHNAME}} {{Subst:CURRENTYEAR}}}} {{Subst:Nul| ← do not change this line, it will set the date automatically}} '''SEE-FIM Protocol''' == 1 Definition == The SEE-FIM protocol is a pathology dissection protocol for Sectioning and Extensively Examining the Fimbria (SEE-FIM). This and similarly designed protocols are intended to provide for the optimal microscopic examination of the distal fallo...' |
